Company Metrics
LIXT Bitcoin Exposure
LIXT Valuation Metrics
LIXT Stock Returns
LIXT Trading & Risk
LIXT Options
About LIXTE Biotechnology's Bitcoin Treasury Strategy
LIXTE Biotechnology (LIXT) ranks #160 globally among Bitcoin treasury companies, with 10.5 Bitcoin in its corporate treasury worth approximately $860.16K at current prices. This represents 0.000% of the total 21 million Bitcoin that will ever exist.
Trading at a stock price of $7.21 per share with a market capitalization of $125.36M, LIXTE Biotechnology's stock currently trades at an mNAV (enterprise value to Bitcoin NAV multiple) of 145.74x. Bitcoin holdings represent 1% of the company's market cap, underscoring Bitcoin's central role in LIXTE Biotechnology's balance sheet strategy.
LIXTE Biotechnology currently trades -13.96% from its 52-week high. The stock averages $2.00M in daily trading volume over the past 30 days, with 30-day volatility at β.